Published in Mol Cell Biol on January 01, 2000
Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A (2001) 2.78
Genomic disorders on 22q11. Am J Hum Genet (2002) 2.63
Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol (2008) 2.01
Establishment of a tissue-specific RNAi system in C. elegans. Gene (2007) 1.82
Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy. Proc Natl Acad Sci U S A (2004) 1.51
Proteasome activator PA200 is required for normal spermatogenesis. Mol Cell Biol (2006) 1.38
Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One (2010) 1.37
Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci U S A (2014) 1.15
PiggyBac transgenic strategies in the developing chicken spinal cord. Nucleic Acids Res (2009) 1.12
Contemporary approaches for modifying the mouse genome. Physiol Genomics (2008) 1.10
Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J Mol Cell Biol (2015) 1.07
Cre-loxP recombination system for large genome rearrangements in Lactococcus lactis. Appl Environ Microbiol (2002) 1.07
CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei. Mol Biochem Parasitol (2007) 1.05
Mislocalization and degradation of human P23H-rhodopsin-GFP in a knockin mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 1.04
Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice. Nucleic Acids Res (2011) 1.01
Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. PLoS Genet (2006) 0.95
Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region. Proc Natl Acad Sci U S A (2000) 0.93
Interdigitated deletion complexes on mouse chromosome 5 induced by irradiation of embryonic stem cells. Genome Res (2000) 0.93
Efficient generation of long-distance conditional alleles using recombineering and a dual selection strategy in replicate plates. BMC Biotechnol (2009) 0.93
An efficient method to generate chromosomal rearrangements by targeted DNA double-strand breaks in Drosophila melanogaster. Genome Res (2004) 0.92
Synapse-specific control of experience-dependent plasticity by presynaptic NMDA receptors. Neuron (2014) 0.91
When Cre-mediated recombination in mice does not result in protein loss. Genetics (2010) 0.90
Conditional gene expression in the mouse inner ear using Cre-loxP. J Assoc Res Otolaryngol (2012) 0.89
Inducing segmental aneuploid mosaicism in the mouse through targeted asymmetric sister chromatid event of recombination. Genetics (2008) 0.86
The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol (2000) 0.86
Creating a transloxation. Engineering interchromosomal translocations in the mouse. EMBO Rep (2000) 0.86
Rapid generation of nested chromosomal deletions on mouse chromosome 2. Proc Natl Acad Sci U S A (2000) 0.83
Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic Acids Res (2013) 0.83
Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis. Cancer Metastasis Rev (2013) 0.82
A genetic strategy for stochastic gene activation with regulated sparseness (STARS). PLoS One (2009) 0.79
Chromosomal manipulation by site-specific recombinases and fluorescent protein-based vectors. PLoS One (2010) 0.78
Impaired glucose tolerance in a mouse model of sidt2 deficiency. PLoS One (2013) 0.78
Applications of the site-specific recombinase Cre to the study of genomic imprinting. Brief Funct Genomics (2010) 0.78
Cre Activated and Inactivated Recombinant Adeno-Associated Viral Vectors for Neuronal Anatomical Tracing or Activity Manipulation. Curr Protoc Neurosci (2015) 0.76
Controlled somatic and germline copy number variation in the mouse model. Curr Genomics (2010) 0.76
An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice. Lupus (2015) 0.76
"Cre/loxP plus BAC": a strategy for direct cloning of large DNA fragment and its applications in Photorhabdus luminescens and Agrobacterium tumefaciens. Sci Rep (2016) 0.76
A murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletions. Retrovirology (2004) 0.75
Opposing roles for SNAP23 in secretion in exocrine and endocrine pancreatic cells. J Cell Biol (2016) 0.75
Generation of a Mouse Full-length Balancer with Versatile Cassette-shuttling Selection Strategy. Int J Biol Sci (2016) 0.75
Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton. Dev Biol (2015) 0.75
Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet (1998) 7.93
Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci U S A (1997) 7.42
Chromosome engineering in mice. Nature (1995) 5.48
Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest (1997) 5.19
Inducible gene targeting in mice using the Cre/lox system. Methods (1998) 4.61
Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet (1997) 4.15
Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A (1994) 3.61
Gene targeting in embryonic stem cells. Methods Enzymol (1993) 3.41
A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet (1995) 3.10
Double-strand gap repair in a mammalian gene targeting reaction. Mol Cell Biol (1991) 2.28
Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res (1990) 2.13
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Engineering a mouse balancer chromosome. Nat Genet (1999) 1.68
A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res (1999) 1.61
Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics (1998) 1.41
Cloning high molecular weight DNA fragments by the bacteriophage P1 system. Trends Genet (1992) 1.37
Induced chromosomal exchange directs the segregation of recombinant chromatids in mitosis of Drosophila. Genetics (1998) 1.34
X-ray-induced mutations in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1998) 1.18
A general model for site-specific recombination by the integrase family recombinases. Nucleic Acids Res (1999) 1.02
Mapping human YAC clones by fluorescence in situ hybridization using Alu-PCR from single yeast colonies. Methods Mol Biol (1994) 0.95
Genetic approaches to the study of the molecular basis of human cancer. Cancer Res (1991) 0.86
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell (1991) 14.89
p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (1999) 13.21
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell (1990) 10.99
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54
Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet (1996) 6.06
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01
A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development (1999) 5.85
Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68
Chromosome engineering in mice. Nature (1995) 5.48
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature (1999) 4.74
Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (1986) 4.73
Requirement for Wnt3 in vertebrate axis formation. Nat Genet (1999) 4.68
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 4.61
Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (2001) 4.41
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene (1993) 4.03
Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev (1995) 3.84
Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature (1991) 3.83
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57
Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54
Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet (1999) 3.47
Gene targeting in embryonic stem cells. Methods Enzymol (1993) 3.41
Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29
Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet (2000) 3.28
Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol Cell Biol (1991) 3.25
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12
Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A (1999) 3.06
Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem (1992) 3.05
Multiple defects and perinatal death in mice deficient in follistatin. Nature (1995) 2.96
The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol (1991) 2.75
Mouse ENU mutagenesis. Hum Mol Genet (1999) 2.72
Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1998) 2.71
Functional analysis of activins during mammalian development. Nature (1995) 2.71
The tumor suppressor p53. Biochim Biophys Acta (1993) 2.65
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62
Different phenotypes for mice deficient in either activins or activin receptor type II. Nature (1995) 2.62
Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature (1999) 2.60
Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J (1993) 2.57
Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell (1993) 2.45
Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol (1996) 2.44
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41
A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature (1987) 2.33
Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32
Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol (1993) 2.32
The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell (1992) 2.27
Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A (1995) 2.27
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26
Clinical and pharmacological properties of ivermectin in rabbits and guinea pigs. Vet Rec (1992) 2.21
Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20
Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog (1995) 2.18
The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev (1995) 2.07
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00
Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev (1994) 1.99
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet (1996) 1.93
Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J (2000) 1.91
Altered segmental identity and abnormal migration of motor neurons in mice lacking Hoxb-1. Nature (1997) 1.89
Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A (1994) 1.88
Engineering chromosomal rearrangements in mice. Nat Rev Genet (2001) 1.85
Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer (2008) 1.78
The role and fate of DNA ends for homologous recombination in embryonic stem cells. Mol Cell Biol (1992) 1.71
A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. Clin Radiol (2007) 1.70
Engineering a mouse balancer chromosome. Nat Genet (1999) 1.68
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc Natl Acad Sci U S A (1996) 1.62
Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol (1999) 1.61
A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res (1999) 1.61
A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60
Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60
High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57
Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol (1999) 1.55
The effects of contrast on visual orientation and spatial frequency discrimination: a comparison of single cells and behavior. J Neurophysiol (1987) 1.51
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet (1995) 1.49
Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci (2000) 1.49
Visual orientation and spatial frequency discrimination: a comparison of single neurons and behavior. J Neurophysiol (1987) 1.49
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. Genesis (2000) 1.49
An anchored framework BAC map of mouse chromosome 11 assembled using multiplex oligonucleotide hybridization. Genomics (1998) 1.46
Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet (1995) 1.43
The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humans. Appl Opt (1992) 1.41
Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics (1998) 1.41
Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res (1995) 1.40
The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol (2005) 1.40
Disruption of an imprinted gene cluster by a targeted chromosomal translocation in mice. Nat Genet (2001) 1.38
Recycling selectable markers in mouse embryonic stem cells. Mol Cell Biol (1996) 1.34
Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev (1995) 1.34
Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience (2002) 1.33
How reliable are commercial allergy tests? Lancet (1987) 1.32